The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q2 2011. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
| Rank |
Drug |
Sales ($000) |
|
|
| 1 |
Lipitor
Pfizer Inc |
1,949,372 |
2.11% |
Stats |
| 2 |
Plavix
Bristol-Myers Squibb Company |
1,698,357 |
2.61% |
Stats |
| 3 |
Nexium
AstraZeneca Pharmaceuticals |
1,528,073 |
-1.65% |
Stats |
| 4 |
Abilify
Otsuka Pharmaceutical Co. |
1,266,791 |
2.79% |
Stats |
5 ( 3) |
Singulair
Merck & Co., Inc. |
1,160,959 |
11.74% |
Stats |
6 ( 1) |
Advair Diskus
GlaxoSmithKline |
1,141,117 |
-2.39% |
Stats |
| 7 (1) |
Seroquel
AstraZeneca Pharmaceuticals |
1,129,442 |
-0.33% |
Stats |
| 8 (1) |
Crestor
AstraZeneca Pharmaceuticals |
1,072,498 |
2.32% |
Stats |
| 9 |
Actos
Takeda Pharmaceuticals North America, Inc |
876,359 |
-13.56% |
Stats |
| 10 (2) |
Remicade
Centocor Ortho Biotech, Inc |
865,903 |
7.61% |
Stats |
| 11 (2) |
Zyprexa
Eli Lilly and Company |
863,890 |
7.93% |
Stats |
| 12 (2) |
Cymbalta
Eli Lilly and Company |
861,431 |
5.03% |
Stats |
| 13 (2) |
Enbrel
Amgen Inc. |
848,230 |
3.77% |
Stats |
| 14 |
Humira
Abbott Laboratories |
844,296 |
6.32% |
Stats |
| 15 |
Neulasta
Amgen Inc. |
818,068 |
4.04% |
Stats |
| 16 (4) |
Rituxan
Genentech, Inc |
734,378 |
7.26% |
Stats |
| 17 |
OxyContin
|
726,420 |
2.82% |
Stats |
| 18 |
Lexapro
Forest Pharmaceuticals, Inc |
720,870 |
3.15% |
Stats |
| 19 (3) |
Copaxone
Teva Pharmaceuticals |
720,747 |
0.29% |
Stats |
| 20 (1) |
Epogen
Amgen Inc. |
720,376 |
3.32% |
Stats |
| 21 |
Avastin
Genentech, Inc |
649,802 |
-1.29% |
Stats |
| 22 |
Atripla
Gilead Sciences, Inc. |
624,469 |
6.31% |
Stats |
| 23 |
Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc |
579,164 |
3.82% |
Stats |
| 24 (3) |
Januvia
Merck & Co., Inc. |
509,786 |
8.81% |
Stats |
| 25 (1) |
Diovan
Novartis Corporation |
497,049 |
5.84% |
Stats |
| 26 (2) |
Lantus
Sanofi-Aventis |
488,609 |
-3.90% |
Stats |
| 27 (1) |
Truvada
Gilead Sciences, Inc. |
481,921 |
8.66% |
Stats |
| 28 (1) |
Celebrex
Pfizer Inc |
443,024 |
1.25% |
Stats |
| 29 (1) |
Lyrica
Pfizer Inc |
439,764 |
0.72% |
Stats |
| 30 (3) |
Lucentis
Genentech, Inc |
424,611 |
0.95% |
Stats |
| 31 (3) |
Diovan HCT
Novartis Corporation |
423,209 |
4.51% |
Stats |
| 32 (4) |
Herceptin
Genentech, Inc |
398,348 |
3.62% |
Stats |
| 33 (4) |
Avonex
Biogen Idec |
379,639 |
2.45% |
Stats |
| 34 (5) |
Namenda
Forest Pharmaceuticals, Inc |
369,408 |
5.72% |
Stats |
| 35 (3) |
One Touch Ultra
|
368,206 |
2.37% |
Stats |
| 36 (5) |
Lantus Solostar
Sanofi-Aventis |
359,907 |
7.80% |
Stats |
| 37 (3) |
Gleevec
Novartis Corporation |
353,382 |
1.64% |
Stats |
| 38 (7) |
venlafaxine
Generic |
339,124 |
-21.22% |
Stats |
| 39 (8) |
enoxaparin
Generic |
336,755 |
8.08% |
Stats |
| 40 (2) |
Zetia
Merck & Co., Inc. |
335,530 |
1.10% |
Stats |
| 41 (7) |
Procrit
Janssen Pharmaceuticals, Inc |
332,466 |
7.04% |
Stats |
| 42 (1) |
TriCor
Abbott Laboratories |
322,121 |
-0.60% |
Stats |
| 43 (1) |
Geodon
Pfizer Inc |
322,015 |
-0.33% |
Stats |
| 44 (5) |
Vyvanse
Shire US Inc |
305,102 |
-1.39% |
Stats |
| 45 (5) |
Niaspan
Abbott Laboratories |
302,949 |
0.54% |
Stats |
| 46 (6) |
Lidoderm
Endo Pharmaceuticals |
295,814 |
1.37% |
Stats |
| 47 (6) |
Suboxone
Reckitt Benckiser Pharmaceuticals Inc. |
293,115 |
3.08% |
Stats |
| 48 (3) |
Aranesp
Amgen Inc. |
291,873 |
-1.03% |
Stats |
| 49 (7) |
AndroGel
Abbott Laboratories |
282,613 |
6.52% |
Stats |
| 50 (20) |
Provigil
Cephalon, Inc. |
275,098 |
17.28% |
Stats |
| 51 (4) |
Nasonex
Merck & Co., Inc. |
270,076 |
0.96% |
Stats |
| 52 (27) |
Levaquin
Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
269,642 |
-42.70% |
Stats |
| 53 (8) |
Lovenox
Sanofi-Aventis |
265,753 |
-17.22% |
Stats |
| 54 |
Vytorin
Merck & Co., Inc. |
265,600 |
-4.04% |
Stats |
55 ( ) |
Eloxatin
Sanofi-Aventis |
263,326 |
 |
Stats |
| 56 (24) |
Concerta
|
261,309 |
-37.94% |
Stats |
| 57 (1) |
Combivent
Boehringer Ingelheim Pharmaceuticals, Inc |
256,985 |
-1.62% |
Stats |
| 58 (7) |
Lovaza
GlaxoSmithKline |
254,718 |
3.98% |
Stats |
| 59 (2) |
Rebif
|
253,780 |
0.25% |
Stats |
| 60 (2) |
Symbicort
AstraZeneca Pharmaceuticals |
252,502 |
0.64% |
Stats |
| 61 (5) |
Novolog
Novo Nordisk Inc. |
252,010 |
3.16% |
Stats |
| 62 (1) |
Adderall XR
Shire US Inc |
251,839 |
1.34% |
Stats |
| 63 (4) |
Alimta
Eli Lilly and Company |
251,739 |
3.76% |
Stats |
| 64 (5) |
Viagra
Pfizer Inc |
249,921 |
-2.00% |
Stats |
| 65 (3) |
Seroquel XR
AstraZeneca Pharmaceuticals |
249,529 |
2.86% |
Stats |
| 66 (9) |
amphetamine/dextroamphetamine
Generic |
246,683 |
7.09% |
Stats |
| 67 (5) |
Humalog
Eli Lilly and Company |
244,050 |
4.83% |
Stats |
| 68 (1) |
metoprolol
Generic |
240,868 |
0.96% |
Stats |
| 69 (5) |
Flovent HFA
GlaxoSmithKline |
237,395 |
-3.77% |
Stats |
| 70 (4) |
Neupogen
Amgen Inc. |
236,294 |
2.51% |
Stats |
| 71 (5) |
Reyataz
Bristol-Myers Squibb Company |
232,090 |
1.96% |
Stats |
| 72 (1) |
Aciphex
Eisai Corporation |
223,768 |
-4.54% |
Stats |
| 73 (5) |
fentanyl
Generic |
216,512 |
-0.62% |
Stats |
| 74 (1) |
ProAir HFA
Teva Pharmaceuticals |
215,302 |
-6.71% |
Stats |
| 75 (5) |
Levemir
Novo Nordisk Inc. |
198,189 |
-0.11% |
Stats |
| 76 (3) |
Lunesta
Sunovion Pharmaceuticals Inc. |
195,242 |
-2.53% |
Stats |
| 77 () |
Varivax
Merck & Co., Inc. |
194,653 |
|
Stats |
| 78 (11) |
Janumet
Merck & Co., Inc. |
193,079 |
8.93% |
Stats |
| 79 (33) |
donepezil
Generic |
190,931 |
-39.00% |
Stats |
| 80 (1) |
Cialis
Eli Lilly and Company |
190,377 |
0.51% |
Stats |
| 81 (16) |
bupropion
Generic |
186,452 |
8.02% |
Stats |
| 82 () |
docetaxel
Generic |
185,282 |
|
Stats |
| 83 () |
methylphenidate
Generic |
184,330 |
|
Stats |
| 84 (16) |
Isentress
Merck & Co., Inc. |
183,544 |
7.95% |
Stats |
| 85 (2) |
valacyclovir
Generic |
183,317 |
-0.78% |
Stats |
| 86 (7) |
NovoLog FlexPen
Novo Nordisk Inc. |
181,733 |
3.71% |
Stats |
| 87 (4) |
Evista
Eli Lilly and Company |
180,730 |
2.43% |
Stats |
| 88 (2) |
Restasis
Allergan, Inc |
179,182 |
1.43% |
Stats |
| 89 (4) |
Betaseron
Bayer Healthcare Pharmaceuticals |
178,938 |
-2.17% |
Stats |
| 90 (2) |
Solodyn
Medicis Pharmaceutical Corporation |
178,722 |
1.84% |
Stats |
| 91 (9) |
Zyvox
Pfizer Inc |
177,583 |
-4.59% |
Stats |
| 92 (2) |
Benicar
Daiichi Sankyo |
172,226 |
-1.37% |
Stats |
| 93 (2) |
Erbitux
Bristol-Myers Squibb Company |
172,185 |
-0.89% |
Stats |
| 94 () |
Velcade
Takeda Pharmaceuticals North America, Inc |
166,629 |
|
Stats |
| 95 (18) |
budesonide
Generic |
166,615 |
-24.47% |
Stats |
| 96 (8) |
Zometa
|
166,150 |
-6.47% |
Stats |
| 97 () |
VESIcare
Astellas Pharma US |
161,704 |
|
Stats |
| 98 () |
acetaminophen/hydrocodone
Generic |
160,975 |
|
Stats |
| 99 () |
Synthroid
Abbott Laboratories |
160,142 |
|
Stats |
| 100 (2) |
Detrol LA
Pfizer Inc |
157,782 |
-7.49% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
3)
1)
)
